Karyopharm Therapeutics (KPTI) Finished Goods (2019 - 2026)
Karyopharm Therapeutics' Finished Goods was $199,000 in Q2 2026, down 43.0% from $349,000 a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Finished Goods (2019 - 2026) Analysis & Trends
At the end of FY2025, Finished Goods at Karyopharm Therapeutics came in at $430,000, down 9.9% from FY2024.
- Finished Goods has now declined for three consecutive years, though with a five-year compound annual growth rate of 40.3% (FY2020 to FY2025).
- In earlier years, Finished Goods was $477,000 in FY2024 (-37.1%), $758,000 in FY2023 (-22.3%), $976,000 in FY2022 (+135.7%) and $414,000 in FY2021 (+424.1%).
- The Q2 2026 figure marks the lowest quarterly Finished Goods since Q1 2021.
- The best year-over-year quarter for Finished Goods over five years was Q4 2021 (growth of 424.1%); the worst was Q1 2025 (a decline of 44.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Karyopharm Therapeutics | 12.16 Mn | -214.27 Mn | 32.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 199,000.00 |
| Dec 31, 2025 | 430,000.00 |
| Sep 30, 2025 | 433,000.00 |
| Jun 30, 2025 | 349,000.00 |
| Mar 31, 2025 | 351,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Sep 30, 2024 | 542,000.00 |
| Jun 30, 2024 | 598,000.00 |
| Mar 31, 2024 | 627,000.00 |
| Dec 31, 2023 | 758,000.00 |
| Sep 30, 2023 | 759,000.00 |
| Jun 30, 2023 | 848,000.00 |
| Mar 31, 2023 | 936,000.00 |
| Dec 31, 2022 | 976,000.00 |
| Sep 30, 2022 | 991,000.00 |
| Jun 30, 2022 | 343,000.00 |
| Mar 31, 2022 | 385,000.00 |
| Dec 31, 2021 | 414,000.00 |
| Sep 30, 2021 | 398,000.00 |
| Jun 30, 2021 | 223,000.00 |
API Access
Karyopharm Therapeutics Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();